Name: Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study (Hart Studies in law and Health) (en Inglés)
SKU: 56103722
Price: 411162.00 COP
Availability: InStock
Author: Margherita Colangelo
ISBN: 9781509965519

portada Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study (Hart Studies in law and Health) (en Inglés)

Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study (Hart Studies in law and Health) (en Inglés)

Formato

Libro Físico

Editorial

Hart Publishing

Autor

Margherita Colangelo

Idioma

Inglés

N° páginas

256

Encuadernación

Tapa Dura

ISBN13

9781509965519

Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study (Hart Studies in law and Health) (en Inglés)

Margherita Colangelo (Autor) · Hart Publishing · Tapa Dura

Libro Nuevo Importado

Envío: 13 a 17 días háb.

$ 822.323$ 411.162

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 411.162

¡Envío Gratis! Llega entre el 06 Oct y el 14 Oct a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study (Hart Studies in law and Health) (en Inglés)"

This book explores the fundamental and inextricable relationship between regulation, intellectual property, competition law, and public health in pharmaceutical markets, examining their interconnections and the delicate balance between the various interests and policy goals at stake. Although pharmaceutical markets are heavily regulated and subject to close antitrust scrutiny, there is a constant requirement for existing rules and policies to tackle a number of persistent, complex issues. The variety of anti-competitive practices occurring in this sector, the worrying rise in drug prices, and major, far-reaching concerns over the accessibility of medicines are sources of frequent controversy in academic and policy debates. Understanding the unique features and dynamics of the pharmaceutical industry requires a tailored and multifaceted approach. The study is enhanced by the adoption of a comparative perspective, tracing convergence and divergence between EU and US systems through the analysis of relevant applicable rules, significant cases, and policy choices. Pursuant to this rigorous approach, the book provides an original and thought-provoking critique of the challenges of regulating pharmaceutical markets.